Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 351

Germany – Mittelstand forever?

Innovative region: Germany

Mar 5, 2019

Ravina rises at Engie EPS

Engie New Ventures alumnus Giovanni Ravina, became chief innovation officer for another Engie subsidiary, Engie EPS, in January this year.

Mar 5, 2019

Imperial internalises tech transfer

ICL will restore internal tech transfer activities from its Imperial White City Incubator, in the process ending its arrangement with commercialisation firm IP Group.

Mar 4, 2019

Shell takes Limejump in acquisition deal

Statkraft Ventures is set to exit distributed energy software provider Limejump in an acquisition by Shell that will follow some $10m of funding for the company.

Mar 4, 2019

Corporate venturing deal net: 25 February - 1 March 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Mar 1, 2019

PetMedix paddles to $10.6m series A

Sanger Institute-founded PetMedix is working on antibodies for dogs and cats based on an immune system discovery model that will adapt and extend earlier human health research.

Mar 1, 2019

Fraunhofer befriends EIF for $68m fund

EU-owned institutions including the EIF are pouring capital and assistance into an early-stage tech transfer vehicle for the Fraunhofer network of applied research institutes.

Mar 1, 2019

Nivaura locks up $20m seed round

Fintech developer Nivaura has closed its seed round at $20m after closing a third tranche, with the capital coming from investors including London Stock Exchange, Transamerica, Santander, Linklaters and Orrick.

Feb 28, 2019

Aprea prolongs series C to $62.8m

Karolinska Institute’s oncology spinout Aprea Therapeutics has received a $5.7m series C extension adding to an initial $56.8m close in November 2018 that featured Karolinska Development.

Feb 28, 2019

Aprea prolongs series C to $62.8m

Praktikertjänst-backed oncology company Aprea has received a $5.7m series C extension adding to an initial $56.8m close in November 2018 that featured Karolinska Development.

Feb 28, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here